Understanding Cholesterol Numbers

The components

LDL cholesterol is the fraction most strongly associated with atherosclerotic cardiovascular disease, and lowering it reduces risk. It is the primary treatment target.

HDL cholesterol is inversely associated with risk in observational data, though interventions that raise it have not reliably reduced events, which complicates the simple good-versus-bad framing.

Triglycerides are a separate fat fraction, influenced strongly by alcohol, refined carbohydrate, and metabolic conditions.

Non-HDL cholesterol — total minus HDL — captures all the potentially atherogenic particles and is increasingly used because it does not require fasting.

Risk matters more than any single number

The same LDL value carries very different implications for a 35-year-old non-smoker with normal blood pressure and a 65-year-old smoker with diabetes.

Clinical practice uses risk calculators combining age, sex, blood pressure, smoking status, diabetes and lipid values to estimate the probability of a cardiovascular event over a period. Treatment decisions follow that estimate rather than the cholesterol figure alone.

This is why two people with identical results may receive different advice, which frequently confuses patients comparing notes.

Fasting, and whether it matters

Guidelines in many places no longer require fasting for routine lipid testing, because non-fasting samples predict risk comparably well.

Triglycerides are the measure most affected by recent eating, so fasting may still be requested where those are the focus.

What lowers LDL

Dietary change has a modest but real effect: reducing saturated fat intake, increasing soluble fibre from oats, legumes and fruit, and plant sterols where used consistently.

Physical activity affects triglycerides and HDL more than LDL, and improves cardiovascular risk through several routes independent of lipids.

Weight reduction where relevant improves the overall pattern, particularly triglycerides.

Statins remain the best-evidenced pharmacological treatment for reducing cardiovascular events, with a large body of trial data. Other classes exist for those who cannot tolerate them or need additional lowering.

Familial hypercholesterolaemia

An inherited condition causing very high LDL from birth, considerably more common than generally realised, and substantially underdiagnosed.

It matters because risk accumulates from an early age and treatment is effective. Very high LDL values, a family history of early heart disease, or cholesterol deposits visible in tendons or around the eyes should prompt specific assessment.

Discussing results

Ask for your calculated risk rather than just the numbers, and ask what the treatment would be expected to change. Absolute risk reduction is more informative than relative reduction.